Inhalation Anesthesia Market

Inhalation Anesthesia Market, By Product (Sevoflurane, Desflurane, Isoflurane, and Nitrous Oxide), By Application (Induction and Maintenance), By End Users (Hospitals and Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics:

Increasing prevalence of chronic disease, growing geriatric (aging) population, increasing number of emergency cases and surgical interventions, increase in demand for inhalation anesthesia, and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global inhalation anesthesia market during the forecast period.

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study:
  • This report provides in-depth analysis of the global inhalation anesthesia market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.
Detailed Segmentation:
  • Global Inhalation Anesthesia Market, By Product:
Sevoflurane

Desflurane

Isoflurane

Nitrous Oxide
  • Global Inhalation Anesthesia Market, By Application:
Induction

Maintenance
  • Global Inhalation Anesthesia Market, By End User:
Hospitals

Ambulatory Surgical Centers
  • Global Inhalation Anesthesia Market, By Geography:
North America

Europe

Asia Pacific

Latin America

Middle East & Africa
  • Company Profiles:
Abbvie Inc.

Novartis AG

Piramal Enterprises Ltd.

Hikma Pharmaceuticals Plc

Fresenius SE & CO. KgaA

Baxter International Inc.

Troikaa Pharmaceuticals, Ltd.

Halocarbon Products Corporation

Jiangsu Hengrui Medicine Co., Ltd.

Lunan Pharmaceutical Group Co. Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
High burden of chronic disease and growing geriatric population
Side-effects and rise in demand or adoption of generic drugs
Increasing demand or use of novel inhalation anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Inhalation Anesthesia Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Inhalation Anesthesia Market, By Product, 2017-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Sevoflurane
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Desflurane
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Isoflurane
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Nitrous Oxide
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Inhalation Anesthesia Market, By Application, 2017-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Induction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Maintenance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
7. Global Inhalation Anesthesia Market, By End User, 2017-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
8. Global Inhalation Anesthesia Market, By Geography, 2017-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
9. Competitive Landscape
Abbvie Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Piramal Enterprises Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hikma Pharmaceuticals Plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fresenius SE & CO. KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Baxter International Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Troikaa Pharmaceuticals, Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Halocarbon Products Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Jiangsu Hengrui Medicine Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Lunan Pharmaceutical Group Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Inhalation Anesthesia Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings